The reported statements, read against the company's own industry.
Financials view
Market Capitalization
4.38BCNY
656.66M · vs all stocks (USD)
Updated Nov 18, 2026
Revenue (TTM)
6.33BCNY
949.68M · vs all stocks (USD)
Updated Nov 18, 2026
Profit Margin
-4.82%
vs Conglomerates peers
Updated Nov 18, 2026
Beta
0.4050x
vs all stocks
Updated Nov 18, 2026
52-Week Change
-30.07%
vs all stocks
Updated Nov 18, 2026
Market Capitalization
4.38BCNY
656.66M · vs all stocks (USD)
Updated Nov 18, 2026
Enterprise Value
26.26BCNY
3.94B · vs all stocks (USD)
Updated Nov 18, 2026
Price to Sales (TTM)
0.6961x
vs Conglomerates peers
Updated Nov 18, 2026
Price to Book (MRQ)
0.8118x
vs Conglomerates peers
Updated Nov 18, 2026
Enterprise to Revenue
4.15x
vs Conglomerates peers
Updated Nov 18, 2026
Enterprise to EBITDA
29.05x
vs Conglomerates peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 23.5×.Updated Nov 18, 2026
Gross Margin
13.85%
vs Conglomerates peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 11.54%.Updated Nov 18, 2026
Profit Margin
-4.82%
vs Conglomerates peers
Updated Nov 18, 2026
Operating Margin
6.63%
vs Conglomerates peers
Updated Nov 18, 2026
Return on Assets (TTM)
0.65%
vs Conglomerates peers
Updated Nov 18, 2026
Return on Equity (TTM)
-8.06%
vs Conglomerates peers
Updated Nov 18, 2026
Revenue (TTM)
6.33BCNY
949.68M · vs all stocks (USD)
Updated Nov 18, 2026
Revenue per Share (TTM)
4.30CNYUpdated Nov 18, 2026
Quarterly Revenue Growth
-89.80%
vs Conglomerates peers
Updated Nov 18, 2026
Gross Profit (TTM)
730.61MCNY
109.58M · vs all stocks (USD)
Updated Nov 18, 2026
EBITDA (TTM)
1.12BCNY
167.58M · vs all stocks (USD)
Updated Nov 18, 2026
Net Income (TTM)
-305.29MCNY
-45.79M · vs all stocks (USD)
Updated Nov 18, 2026
Operating Cash Flow (TTM)
76.37MCNY
11.46M · vs all stocks (USD)
Updated Nov 18, 2026
Levered Free Cash Flow (TTM)
-675.91MCNY
-101.38M · vs all stocks (USD)
Updated Nov 18, 2026
5-Year Average Dividend Yield
0.43%
vs all stocks
Updated Nov 18, 2026
Payout Ratio
94.64%
vs Conglomerates peers
Updated Nov 18, 2026
Minority Interest (Equity)
1.40BCNYFY2025 · Dec 31, 2025
Revenue
17.87BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
16.91BCNYFY2025 · Dec 31, 2025
Gross Profit
954.39MCNYFY2025 · Dec 31, 2025
Operating Income
667.43MCNY
100.11M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-436.63MCNYFY2025 · Dec 31, 2025
Income Tax Expense
82.56MCNYFY2025 · Dec 31, 2025
Net Income
-519.19MCNYFY2025 · Dec 31, 2025
EBIT
433.56MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
1.12BCNYFY2025 · Dec 31, 2025
Research & Development
34.98MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
62.43MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
75.92MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
38.86MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
870.19MCNYFY2025 · Dec 31, 2025
EPS (Basic)
-0.1941CNYFY2025 · Dec 31, 2025
EPS (Diluted)
-0.1941CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
1.47BSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
1.47BSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-519.19MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
233.08MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-684.87MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-1.12BCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
1.28BCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-519.19MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
1.57BCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-2.44BCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
699.38MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-437.05MCNYFY2025 · Dec 31, 2025
Net Acquisitions
2.58BCNYFY2025 · Dec 31, 2025
Purchase of Investments
-24.45MCNYFY2025 · Dec 31, 2025
Sale of Investments
2.92MCNYFY2025 · Dec 31, 2025
Other Investing Activity
2.80MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
2.12BCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
16.42BCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-14.69BCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-1.21BCNYFY2025 · Dec 31, 2025
Other Financing Charges
-1.65BCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-1.12BCNYFY2025 · Dec 31, 2025
Shares Outstanding
1.46BSharesUpdated Nov 18, 2026
Float Shares
991.21MSharesUpdated Nov 18, 2026
% Held by Insiders
5.04%
vs all stocks
Updated Nov 18, 2026
% Held by Institutions
31.95%
vs all stocks
Updated Nov 18, 2026
Total Cash (MRQ)
2.15BCNY
322.02M · vs all stocks (USD)
Updated Nov 18, 2026
Total Cash per Share (MRQ)
1.47CNYUpdated Nov 18, 2026
Total Debt (MRQ)
22.83BCNY
3.42B · vs all stocks (USD)
Updated Nov 18, 2026
Total Debt to Equity (MRQ)
3.46x
vs Conglomerates peers
Updated Nov 18, 2026
Current Ratio (MRQ)
1.14x
vs Conglomerates peers
Updated Nov 18, 2026
Book Value per Share (MRQ)
3.72CNYUpdated Nov 18, 2026
Total Assets
43.01BCNY
6.45B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
27.89BCNYFY2025 · Dec 31, 2025
Total Liabilities
36.19BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
15.12BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
13.18BCNYFY2025 · Dec 31, 2025
Total Current Liabilities
23.01BCNYFY2025 · Dec 31, 2025
Cash
1.31BCNYFY2025 · Dec 31, 2025
Cash Equivalents
2.22BCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
3.53BCNYFY2025 · Dec 31, 2025
Accounts Receivable
10.04BCNYFY2025 · Dec 31, 2025
Inventory
11.31BCNYFY2025 · Dec 31, 2025
Accounts Payable
5.40BCNYFY2025 · Dec 31, 2025
Short-term Debt
12.95BCNYFY2025 · Dec 31, 2025
Other Current Liabilities
43.06MCNYFY2025 · Dec 31, 2025
Long-term Debt
9.55BCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
56.37MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
1.48BCNYFY2025 · Dec 31, 2025
Retained Earnings
2.51BCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
6.82BCNY
1.02B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
27.25MCNYFY2025 · Dec 31, 2025
52-Week Low
2.97CNYUpdated Nov 18, 2026
52-Week High
4.92CNYUpdated Nov 18, 2026
52-Week Change
-30.07%
vs all stocks
Updated Nov 18, 2026
Beta
0.4050x
vs all stocks
Updated Nov 18, 2026
50-Day MA
3.28CNYUpdated Nov 18, 2026
200-Day MA
3.69CNYUpdated Nov 18, 2026
Avg 10-Day Volume
10.19MSharesUpdated Nov 18, 2026
Avg 30-Day Volume
10.12MSharesUpdated Nov 18, 2026
Diluted EPS (TTM)
-0.2100CNYUpdated Nov 18, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Debt is a large share of its assets, and large against its cash flow.
Reads
Elevated Leverage on Three Denominators
Debt sits high against its equity, its assets, and its cash flow.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Debt-to-equity is 3.46×, higher than 95% of its Conglomerates peers (median 0.38×)Significant